It will be important to understand whether MNK inhibition will interfere with the anticancer activity of the chemotherapeutic, but this is unlikely since increased MNK activity and increased eIF4E phosphorylation are associated with many cancers73,74 and MNK inhibitors are currently in clinical trials for cancer treatment.75 The gene discussed is EIF4E; the disease is cancer.